Healthcare Equipment and Supplies
Company Overview of LED Medical Diagnostics, Inc.
LED Medical Diagnostics Inc. operates as a dental imaging services and technology company in North America. Its products include Velscope Vx system to examine the oral mucosa and screen for tissue abnormalities, including early stage oral cancer and pre-cancer; VELscope Vx Camera kit for fluorescence photography; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, the single use plastic sheaths that allow proper ventilation for VELscope Vx scope while preventing debris buildup and cross contamination in the operatory; and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company sells its products to dentists and dental specialists. It ma...
580 Hornby Street
Vancouver, BC V6C 3B6
Founded in 2003
Key Executives for LED Medical Diagnostics, Inc.
Chief Executive Officer, President and Director
Total Annual Compensation: $50.3K
Vice President of Sales & Marketing, Director and President of LED Dental Ltd
Total Annual Compensation: $55.0K
Total Annual Compensation: $286.4K
Compensation as of Fiscal Year 2013.
LED Medical Diagnostics, Inc. Key Developments
LED Medical Diagnostics, Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 11:25 AM
Sep 24 15
LED Medical Diagnostics, Inc. Presents at Aegis Capital Corp 2015 Growth Conference, Oct-09-2015 11:25 AM. Venue: The Encore at Wynn, 3131 S Las Vegas Blvd, Las Vegas, NV 89109, United States.
LED Medical Diagnostics Announces Issuance of Senior Secured Debentures Totaling USD 500,000
Sep 24 15
LED Medical Diagnostics Inc. announced that it is completing the second tranche to the previously announced debenture financing. In this second tranche the Company will issue USD 500,000 of 10% senior secured debentures each in the amount of USD 10,000 and maturing after 12 months. The lender for all Debentures will be the Bloom Burton Healthcare Lending Trust. The subscription price for each Unit is USD 10,000. The Company is granting the Warrants as a loan bonus in accordance with Exchange Policy 5.1 of the TSX Venture Exchange and each such Warrant will entitle the holder thereof to acquire one common share in the capital of the Company for USD 0.28 for a period of 12 months from the closing of the issuance of the Debentures. The proceeds will be used by LED for general corporate purposes. All securities issued in connection with the transaction are subject to a hold period expiring four months after the closing date. The completion of the private placement is subject to final approval of the TSX-Venture Exchange which will be evidenced by the issuance of the Exchange bulletin.
LED Medical Diagnostics's VELscope(R) Vx Receives Regulatory Approval for Distribution in China
Sep 9 15
LED Medical Diagnostics Inc. (LED Medical or the Company) and its subsidiary LED Dental have received regulatory approval for the distribution of the VELscope® Vx Enhanced Oral Assessment System in China, opening up a large new market for the award-winning adjunctive screening device. Geneformation Technology, a distributor of laboratory equipment and consumables with offices in China, Hong Kong and the United States, has worked closely with the Company to obtain regulatory approval for the VELscope Vx from the China Food and Drug Administration. As of August 6, 2015, the VELscope Vx Enhanced Oral Assessment System is approved for sale in China as a medical apparatus, Category I, under approval number ???20151176.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 15, 2015
January 27, 2015